Metabolic Syndrome and Inflammatory Markers - Tabular View

This Tabular View shows the required WHO registration data elements as marked by ^†

Tracking Information

First Received Date ^†

February 8, 2007

Last Updated Date

February 8, 2007

Start Date ^†

August 2006

Current Primary Outcome Measures ^†

Measuring inflammatory markers in metabolic syndrome

Original Primary Outcome Measures ^†

Same as current

Change History

No Changes Posted

Current Secondary Outcome Measures ^†

Original Secondary Outcome Measures ^†

Descriptive Information

Brief Title ^†

Metabolic Syndrome and Inflammatory Markers

Official Title ^†

Effect of Fasting With Two Meals on Inflammatory Markers of Metabolic Syndrome

Brief Summary

The metabolic syndrome has been recognized as a proinflammatory state. It has been shown that many different diets such as Mediterranean diet, DASH diet, Foods with low glycemic index and low saturated fat diet, independent of weight loss, may be effective in improving the metabolic syndrome. Our objective was to evaluate the effect of Ramadan fasting on High-sensitive C-reactive protein (hs-CRP) and fibrinogen levels in metabolic syndrome.

Detailed Description

Study Phase

Study Type ^†

Interventional

Study Design ^†

Treatment, Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study

Condition ^†

Metabolic Syndrome

Intervention ^†

Behavioral: Ramadan Fasting

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^†

Completed

Enrollment ^†

Completion Date

November 2006

Primary Completion Date

Eligibility Criteria ^†

Inclusion Criteria:

Males with metabolic syndrome

Exclusion Criteria:

Conditions with insulin resistance including;
Type 2 diabetes mellitus,
Infections,
Stresses,
Uremia,
Acromegaly,
Glucocorticoid excess,
Hypertension ,
Cirrhosis and
Any addiction or drug therapy and conditions witch cause changes in hs-CRP and fibrinogen levels including infection, trauma, infarction, inflammatory arthritis, various neoplasm and liver diseases.

Gender

Male

Ages

Accepts Healthy Volunteers

Contacts ^††

Location Countries ^†

Expanded Access Status

Administrative Information

NCT ID ^†

NCT00433082

Responsible Party

Secondary IDs ^††

Study Sponsor ^†

Free Islamic University of Medical Sciences

Collaborators ^††

Investigators ^†

Principal Investigator:

Zahra Vahdat Shariatpanahi, MD

Islamic Free University of Medical Science

Information Provided By

Free Islamic University of Medical Sciences

Verification Date

February 2007

^† Required WHO trial registration data element.
^†† WHO trial registration data element that is required only if it exists.